GILEAD SCIENCES, INC.

Q4 2024 13F Holdings

  • Location
    foster city, CA
  • Num holdings

    16

  • Value ($000)

    $1,551,148

  • Date Filed
    02/13/2025
  • Form type
    13F-HR
  • CIK
    0000882095
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
ACLX
ACLX

ARCELLX INC

COMMON STOCK
03940C100
$515.42M
33 %

6,720,803

GLPG
GLPG

GALAPAGOS NV

SPON ADR
36315X101
$461.73M
30 %

16,707,477

RCUS
RCUS

ARCUS BIOSCIENCES INC

COM
03969F109
$447.61M
29 %

30,061,124

ASMB
ASMB

ASSEMBLY BIOSCIENCES INC

COM NEW
045396207
$34.87M
2 %

2,209,471

---

MERUS N V

COM
N5749R100
$19.03M
1 %

452,527

KYTX
KYTX

KYVERNA THERAPEUTICS INC

COM
501976104
$15.43M
1 %

4,126,119

LPTX
LPTX

LEAP THERAPEUTICS INC

COM NEW
52187K200
$15.29M
1 %

5,319,148

TNGX
TNGX

TANGO THERAPEUTICS INC

COM
87583X109
$15.00M
1 %

4,854,443

XLO
XLO

XILIO THERAPEUTICS INC

COM
98422T100
$8.70M
1 %

9,105,451

ALVR
ALVR

ALLOVIR INC

COM
019818103
$6.99M
1 %

16,635,286

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 16